Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,086 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Suppression of intestinal carcinogenesis in Apc-mutant mice by limonin.
Shimizu S, Miyamoto S, Fujii G, Nakanishi R, Onuma W, Ozaki Y, Fujimoto K, Yano T, Mutoh M. Shimizu S, et al. Among authors: ozaki y. J Clin Biochem Nutr. 2015 Jul;57(1):39-43. doi: 10.3164/jcbn.15-28. Epub 2015 Jun 17. J Clin Biochem Nutr. 2015. PMID: 26236099 Free PMC article.
Phenolics profile of mume, Japanese apricot (Prunus mume Sieb. et Zucc.) fruit.
Mitani T, Horinishi A, Kishida K, Kawabata T, Yano F, Mimura H, Inaba N, Yamanishi H, Oe T, Negoro K, Mori H, Miyake Y, Hosoda A, Tanaka Y, Mori M, Ozaki Y. Mitani T, et al. Among authors: ozaki y. Biosci Biotechnol Biochem. 2013;77(8):1623-7. doi: 10.1271/bbb.130077. Epub 2013 Aug 7. Biosci Biotechnol Biochem. 2013. PMID: 23924723 Free article.
Impact of Climate on the Incidence of Acute Coronary Syndrome　- Differences Between Japan and Thailand.
Yamano T, Thammakumpee K, Nabkasorn C, Ritngam A, Krungkraipetch N, Kaewwilai L, Suwanmanee S, Phosri A, Kaewboonchoo O, Murakami S, Tanaka R, Murata N, Katayama Y, Taruya A, Takahata M, Wada T, Ota S, Satogami K, Ozaki Y, Kashiwagi M, Shiono Y, Kuroi A, Tanimoto T, Kitabata H, Tanaka A. Yamano T, et al. Among authors: ozaki y. Circ Rep. 2024 Mar 28;6(4):134-141. doi: 10.1253/circrep.CR-24-0012. eCollection 2024 Apr 10. Circ Rep. 2024. PMID: 38606419 Free PMC article.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Ito M, Okumura Y, Nio K, Baba E, Ozaki Y, Nishio H, Ichihara E, Miura Y, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ochi N, Kubo T, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Tsuchihashi K. Ito M, et al. Among authors: ozaki y. Int J Clin Oncol. 2024 Apr 5. doi: 10.1007/s10147-024-02502-6. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38578596
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Kimura S, Shigeta K, Tamura S, Uchino K, Kimura T, Ozaki Y, Nishio H, Tsuchihashi K, Ichihara E, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Miura Y. Kimura S, et al. Among authors: ozaki y. Int J Clin Oncol. 2024 Mar 28. doi: 10.1007/s10147-024-02501-7. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38538963
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Ozaki Y, Yokoe T, Yoshinami T, Nozawa K, Nishio H, Tsuchihashi K, Ichihara E, Miura Y, Endo M, Yano S, Maruyama D, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T. Ozaki Y, et al. Int J Clin Oncol. 2024 Mar 25. doi: 10.1007/s10147-024-02499-y. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38526621
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Uchino K, Tamura S, Kimura S, Shigeta K, Kimura T, Ozaki Y, Nishio H, Tsuchihashi K, Ichihara E, Endo M, Yano S, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Kamiyama Y, Nakao S, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Miura Y. Uchino K, et al. Among authors: ozaki y. Int J Clin Oncol. 2024 Mar 22. doi: 10.1007/s10147-024-02491-6. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38517658
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Maeda T, Najima Y, Kamiyama Y, Nakao S, Ozaki Y, Nishio H, Tsuchihashi K, Ichihara E, Miumra Y, Endo M, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Yano S. Maeda T, et al. Among authors: ozaki y. Int J Clin Oncol. 2024 Mar 18. doi: 10.1007/s10147-023-02465-0. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38494578
2,086 results